(Q39144823)

English

The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection

scientific article published on 26 November 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 September 2017

The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection (English)

1 reference

Europe PubMed Central

9 September 2017

Middle East respiratory syndrome coronavirus

0 references

0 references

1 reference

based on heuristic

inferred from title

Middle East respiratory syndrome

1 reference

based on heuristic

inferred from title

author name string

Lan Jiaming

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27899228%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Yao Yanfeng

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27899228%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Deng Yao

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27899228%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Hu Yawei

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27899228%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Bao Linlin

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27899228%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Huang Baoying

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27899228%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Yan Jinghua

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27899228%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

George F Gao

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27899228%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Qin Chuan

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27899228%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Tan Wenjie

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27899228%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

language of work or name

0 references

publication date

26 November 2016

1 reference

Europe PubMed Central

9 September 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27899228%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

35

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27899228%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

10-18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27899228%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27899228%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

The severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Middle East respiratory syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

[Coronaviruses]

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Receptor recognition mechanisms of coronaviruses: a decade of structural studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Receptor-binding domain-based subunit vaccines against MERS-CoV

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Evaluation of candidate vaccine approaches for MERS-CoV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Rapid generation of a mouse model for Middle East respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

The amino acids 736-761 of the MERS-CoV spike protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Priming with two DNA vaccines expressing hepatitis C virus NS3 protein targeting dendritic cells elicits superior heterologous protective potential in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Middle East respiratory syndrome: current status and future prospects for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Infection with MERS-CoV causes lethal pneumonia in the common marmoset

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Characterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Animal models for SARS and MERS coronaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

A live attenuated severe acute respiratory syndrome coronavirus is immunogenic and efficacious in golden Syrian hamsters

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Antibody-dependent enhancement occurs upon re-infection with the identical serotype virus in feline infectious peritonitis virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Vaccines against respiratory syncytial virus: The time has finally come

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Pneumonia from human coronavirus in a macaque model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.064

7 January 2021

Identifiers

10.1016/J.VACCINE.2016.11.064

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27899228%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27899228%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27899228%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39144823&oldid=1809269944"